Japan Biosimilar Monoclonal Antibodies Market Report 2016

November 2016 | 119 pages | ID: JF7FDEC6980EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biosimilar Monoclonal Antibodies

Revenue, means the sales value of Biosimilar Monoclonal Antibodies

This report studies sales (consumption) of Biosimilar Monoclonal Antibodies in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Celltrion
• Boehringer Ingelheim
• Dr Reddy’s
• Sandoz
• Zydus
• Samsung
• Amgen
• Hospira
• Shanghai CP Guojian Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Monoclonal Antibodies in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Japan Biosimilar Monoclonal Antibodies Market Report 2016

1 BIOSIMILAR MONOCLONAL ANTIBODIES OVERVIEW

1.1 Product Overview and Scope of Biosimilar Monoclonal Antibodies
1.2 Classification of Biosimilar Monoclonal Antibodies
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Biosimilar Monoclonal Antibodies
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Biosimilar Monoclonal Antibodies (2011-2021)
  1.4.1 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2021)
  1.4.2 Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

2 JAPAN BIOSIMILAR MONOCLONAL ANTIBODIES COMPETITION BY MANUFACTURERS

2.1 Japan Biosimilar Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Biosimilar Monoclonal Antibodies Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Biosimilar Monoclonal Antibodies Average Price by Manufactures (2015 and 2016)
2.4 Biosimilar Monoclonal Antibodies Market Competitive Situation and Trends
  2.4.1 Biosimilar Monoclonal Antibodies Market Concentration Rate
  2.4.2 Biosimilar Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 JAPAN BIOSIMILAR MONOCLONAL ANTIBODIES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Japan Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2011-2016)
3.2 Japan Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)
3.3 Japan Biosimilar Monoclonal Antibodies Price by Type (2011-2016)
3.4 Japan Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2011-2016)

4 JAPAN BIOSIMILAR MONOCLONAL ANTIBODIES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Japan Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2011-2016)
4.2 Japan Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 JAPAN BIOSIMILAR MONOCLONAL ANTIBODIES MANUFACTURERS PROFILES/ANALYSIS

5.1 Celltrion
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Boehringer Ingelheim
  5.2.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Dr Reddy’s
  5.3.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sandoz
  5.4.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Zydus
  5.5.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Samsung
  5.6.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Amgen
  5.7.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Hospira
  5.8.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Shanghai CP Guojian Pharmaceutical
  5.9.2 Biosimilar Monoclonal Antibodies Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview

6 BIOSIMILAR MONOCLONAL ANTIBODIES MANUFACTURING COST ANALYSIS

6.1 Biosimilar Monoclonal Antibodies Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Biosimilar Monoclonal Antibodies Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN BIOSIMILAR MONOCLONAL ANTIBODIES MARKET FORECAST (2016-2021)

10.1 Japan Biosimilar Monoclonal Antibodies Sales, Revenue Forecast (2016-2021)
10.2 Japan Biosimilar Monoclonal Antibodies Sales Forecast by Type (2016-2021)
10.3 Japan Biosimilar Monoclonal Antibodies Sales Forecast by Application (2016-2021)
10.4 Biosimilar Monoclonal Antibodies Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilar Monoclonal Antibodies
Table Classification of Biosimilar Monoclonal Antibodies
Figure Japan Sales Market Share of Biosimilar Monoclonal Antibodies by Type in 2015
Table Application of Biosimilar Monoclonal Antibodies
Figure Japan Sales Market Share of Biosimilar Monoclonal Antibodies by Application in 2015
Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2011-2021)
Figure Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate (2011-2021)
Table Japan Biosimilar Monoclonal Antibodies Sales of Key Manufacturers (2015 and 2016)
Table Japan Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Figure 2016 Biosimilar Monoclonal Antibodies Sales Share by Manufacturers
Table Japan Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2015 and 2016)
Table Japan Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 Japan Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers
Table Japan Market Biosimilar Monoclonal Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Biosimilar Monoclonal Antibodies Average Price of Key Manufacturers in 2015
Figure Biosimilar Monoclonal Antibodies Market Share of Top 3 Manufacturers
Figure Biosimilar Monoclonal Antibodies Market Share of Top 5 Manufacturers
Table Japan Biosimilar Monoclonal Antibodies Sales by Type (2011-2016)
Table Japan Biosimilar Monoclonal Antibodies Sales Share by Type (2011-2016)
Figure Japan Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2015
Table Japan Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)
Table Japan Biosimilar Monoclonal Antibodies Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilar Monoclonal Antibodies by Type (2011-2016)
Table Japan Biosimilar Monoclonal Antibodies Price by Type (2011-2016)
Figure Japan Biosimilar Monoclonal Antibodies Sales Growth Rate by Type (2011-2016)
Table Japan Biosimilar Monoclonal Antibodies Sales by Application (2011-2016)
Table Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application (2011-2016)
Figure Japan Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2015
Table Japan Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2011-2016)
Figure Japan Biosimilar Monoclonal Antibodies Sales Growth Rate by Application (2011-2016)
Table Celltrion Basic Information List
Table Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Dr Reddy’s Basic Information List
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dr Reddy’s Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Sandoz Basic Information List
Table Sandoz Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sandoz Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Zydus Basic Information List
Table Zydus Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Zydus Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Samsung Basic Information List
Table Samsung Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Samsung Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Basic Information List
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shanghai CP Guojian Pharmaceutical Biosimilar Monoclonal Antibodies Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies
Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Figure Biosimilar Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Biosimilar Monoclonal Antibodies
Table Distributors/Traders List
Figure Japan Biosimilar Monoclonal Antibodies Production and Growth Rate Forecast (2016-2021)
Figure Japan Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)
Table Japan Biosimilar Monoclonal Antibodies Production Forecast by Type (2016-2021)
Table Japan Biosimilar Monoclonal Antibodies Consumption Forecast by Application (2016-2021)